Drug recall · July 25, 2018
0.2% ROPivacaine - OnQ Pump recall
Why: Lack of Assurance of Sterility: Potential leakage of bags.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP) QS 550 ml, single dose pump. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77056. NDC: 42852-661-02
- Lots / codes
Lot # 5/14/18 0749 525-66102, BUD 6/13/2018; 5/22/18 0837 495-66102, BUD 6/21/2018
- Quantity
- 40 pumps
- Company
- Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
- Distribution
- Nationwide in the USA
- Initiated
- June 12, 2018 · Voluntary: Firm initiated
- Classified
- July 19, 2018
- Reported
- July 25, 2018
- Ended
- January 24, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ropivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.